β-Methyl Digoxin

For research use only. Not for therapeutic Use.

  • CAT Number: R012706
  • CAS Number: 30685-43-9
  • Molecular Formula: C42H66O14
  • Molecular Weight: 794.976
  • Purity: ≥95%
Inquiry Now

&beta;-Methyl Digoxin (CAS&nbsp;30685-43-9)&nbsp;<span style="font-family:arial,helvetica,sans-serif;"><span style="font-size:12px;"><span style="font-variant-ligatures: normal; orphans: 2; widows: 2;">is a cardiotonic methylated digoxin derivative with e<span style="font-variant-ligatures: normal;">nhanced and more complete gastrointestinal absorption. It can be&nbsp;</span></span><span style="font-variant-ligatures: normal; orphans: 2; widows: 2;">used in the treatment of congestive heart failure and cardiac arrhythmia.</span></span></span>


Catalog Number R012706
CAS Number 30685-43-9
Synonyms

(3β,5β,12β)-3-[(O-2,6-Dideoxy-4-O-methyl-β-D-ribo-hexopyranosyl-(14)-O-2,6-dideoxy-β-D-ribo-hexopyranosyl-(14)-2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-12,14-dihydroxycard-20(22)-enolide; 4’’’-Methyldigoxin; 4’’’-O-Methyldigoxin; Lanirapid; Lanitop; M

Molecular Formula C42H66O14
Purity ≥95%
Storage -20°C
IUPAC Name 3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-12,14-dihydroxy-3-[(2R,4S,5S,6R)-4-hydroxy-5-[(2S,4S,5S,6R)-4-hydroxy-5-[(2S,4S,5S,6R)-4-hydroxy-5-methoxy-6-methyloxan-2-yl]oxy-6-methyloxan-2-yl]oxy-6-methyloxan-2-yl]oxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one
InChI InChI=1S/C42H66O14/c1-20-37(49-6)29(43)16-35(51-20)55-39-22(3)53-36(18-31(39)45)56-38-21(2)52-34(17-30(38)44)54-25-9-11-40(4)24(14-25)7-8-27-28(40)15-32(46)41(5)26(10-12-42(27,41)48)23-13-33(47)50-19-23/h13,20-22,24-32,34-39,43-46,48H,7-12,14-19H2,1-6H3/t20-,21-,22-,24-,25+,26-,27-,28+,29+,30+,31+,32-,34+,35+,36+,37-,38-,39-,40+,41+,42+/m1/s1
InChIKey IYJMSDVSVHDVGT-PEQKVOOWSA-N
SMILES CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)OC
Reference

<span style="font-size:12px;"><span style="font-family:arial,helvetica,sans-serif;"><span style="font-variant-ligatures: normal; orphans: 2; widows: 2;">1. Hunter, J., et al., 1993. Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetics of vinblastine secretion and interaction with modulators. The Journal of biological chemistry. 268(20): 14991-7. PMID: 8100817</span><br style="box-sizing: border-box; color: rgb(51, 51, 51); font-family: openSans, arial, sans-serif; font-size: 14px; font-variant-ligatures: normal; orphans: 2; widows: 2;" />
<span style="font-variant-ligatures: normal; orphans: 2; widows: 2;">2. Greiner, B., et al., 1999. The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin. The Journal of clinical investigation. 104(2): 147-53. PMID: 10411543</span><br style="box-sizing: border-box; color: rgb(51, 51, 51); font-family: openSans, arial, sans-serif; font-size: 14px; font-variant-ligatures: normal; orphans: 2; widows: 2;" />
<span style="font-variant-ligatures: normal; orphans: 2; widows: 2;">3. Jun, A S., et al., . High-performance liquid chromatography assay of amiodarone in rat plasma. Journal of pharmacy &amp; pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Soci&eacute;t&eacute; canadienne des sciences pharmaceutiques. 4(3): 263-8. PMID: 11737993</span><br style="box-sizing: border-box; color: rgb(51, 51, 51); font-family: openSans, arial, sans-serif; font-size: 14px; font-variant-ligatures: normal; orphans: 2; widows: 2;" />
<span style="font-variant-ligatures: normal; orphans: 2; widows: 2;">4. Sugiyama, Daisuke., et al., 2002. Effect of 17 beta-estradiol-D-17 beta-glucuronide on the rat organic anion transporting polypeptide 2-mediated transport differs depending on substrates. Drug metabolism and disposition: the biological fate of chemicals. 30(2): 220-3. PMID: 11792694<br />
5.</span></span></span><span style="font-family: Arial, sans-serif; font-size: 13px; font-variant-ligatures: normal; orphans: 2; widows: 2;">Rennekamp, H., et al. &quot;Pharmacokinetic behaviour of 4‴-methyldigoxin in man.&quot;&nbsp;</span><i style="font-family: Arial, sans-serif; font-size: 13px; font-variant-ligatures: normal; orphans: 2; widows: 2;">Naunyn-Schmiedeberg&#39;s archives of pharmacology</i><span style="font-family: Arial, sans-serif; font-size: 13px; font-variant-ligatures: normal; orphans: 2; widows: 2;">&nbsp;273.1-2 (1972): 172-174.</span>

Request a Quote